Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 232

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 7
Chunk 232
---
 2032, 3,600 on May 11, 2033 and 2,700 on June 13, 2034. The weighted average exercise price of these options is  
                                                             NIS 63.12 per ordinary share.                                                       
-------------------------------------------------------------------------------------------------------------------------------------------------

(6)          Consists of 4,950 ordinary shares issuable upon exercise of options that are currently exercisable or exercisable within 60 days       
      of March 17, 2025, of which options to purchase the following number of shares expire on the following dates, respectively: 1,800 on September
        15, 2032, 1,800 on May 11, 2033 and 1,350 on June 13, 2034. The weighted average exercise price of these options is NIS 28.42 per ordinary  
                                                                          share.                                                                    
----------------------------------------------------------------------------------------------------------------------------------------------------

(7)        Consists of 7,450 ordinary shares issuable upon exercise of options that are currently exercisable or exercisable within 60 days     
      of March 17, 2025, of which options to purchase the following number of shares expire on the following dates, respectively: 2,500 on April
        20, 2030, 1,800 on September 15, 2032, 1,800 on May 11, 2033 and 1,350 on June 13, 2034. The weighted average exercise price of these   
                                                         options is $8.90 per ordinary share.                                                   
------------------------------------------------------------------------------------------------------------------------------------------------

(8)          Consists of 8,250 ordinary shares issuable upon exercise of options that are currently exercisable or exercisable within 60 days      
      of March 17, 2025, of which options to purchase the following number of shares expire on the following dates, respectively: 1,000 on December
         23, 2028, 250 on February 1, 2030, 250 on February 1, 2031, 1,800 on August 10, 2031, 1,800 on September 15, 2032, 1,800 on May 11, 2033  
                      and 1,350 on June 13, 2034. The weighted average exercise price of these options is $16.15 per ordinary share.               
---------------------------------------------------------------------------------------------------------------------------------------------------

(9)       Includes 83,886 ordinary shares held by Mr. Recanati.